Quince Therapeutics

QNCXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$31.885 M

$31.35 +1.13%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$84.0M

Loss-making

Shares outstanding

1,017,063

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#135Atyr PharmaATYR$35.0M
#136Genenta Science S.p.A.GNTA$33.9M
#137Quince TherapeuticsQNCX$31.9M
#138Cel SciCVM$29.9M
#139Evaxion A/SEVAX$29.5M

What if Quince Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$29,726,742

Per share 948,221× higher

Bitcoin $1.74T

$1,712,436

Per share 54,623× higher

Nvidia $5.52T

$5,423,230

Per share 172,990× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Quince Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.